A new drug for terminal breast cancer sufferers is "a lifesaver" for women who have had been having chemeo therapy for a long time, one patient told Daybreak.
Mani Coulter said Kadcyla reduced the cancer "immediately" and had "minimal" side effects because it was a targeted drug.
More top news
Merrill Lynch has been fined £34.5 million for failing to report 68.5 million transactions, the Financial Conduct Authority has said.
Most people back a change in the law to ban unpaid internships that last for more than four weeks, a new poll suggests.
The favourites to win the Venice marathon finished behind a local runner - after they were led along the wrong route by a motorcycle guide.